$4.35 -0.02 (-0.458%) Xoma Corp - NASDAQ

Oct. 24, 2014 | 12:48 PM

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
10/15/2014Varian JohnCEO10,000$1.243.07%
10/15/2014Varian JohnCEO-10,000$3.87-2.98%
10/01/2014SCANNON PATRICK J MD PHDExec. VP & CSO-5,000$4.09-5.75%
9/15/2014Varian JohnCEO10,000$1.243.07%
9/15/2014Varian JohnCEO-10,000$4.56-2.98%
9/15/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO5,000$3.046.94%
9/15/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO-5,000$4.59-6.49%
9/04/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO10,000$3.0413.88%
9/04/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO-10,000$4.56-12.19%
9/02/2014SCANNON PATRICK J MD PHDExec. VP & CSO-5,000$4.31-5.44%
8/18/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO-16,449$4.36-18.59%
8/15/2014Neal James RVP Business Development-6,584$4.61-4.35%
8/15/2014SCANNON PATRICK J MD PHDExec. VP & CSO-5,871$4.31-6.00%
8/15/2014Varian JohnCEO-54,823$4.31-14.42%
8/15/2014Varian JohnCEO-10,000$4.30-2.98%
8/15/2014KURLAND FREDCFO & VP Finance-10,401$4.31-12.74%
8/15/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO-10,299$4.31-10.43%
8/15/2014Varian JohnCEO10,000$1.243.07%
8/01/2014SCANNON PATRICK J MD PHDExec. VP & CSO-5,000$3.83-5.78%
7/15/2014Varian JohnCEO-10,000$4.03-3.38%
7/15/2014Varian JohnCEO10,000$1.243.50%
7/01/2014SCANNON PATRICK J MD PHDExec. VP & CSO-5,000$4.68-5.46%
6/16/2014Varian JohnCEO-10,000$4.54-3.38%
6/16/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO-11,580$4.54-13.85%
6/16/2014Varian JohnCEO10,000$1.243.50%
5/28/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO-1,785$4.22-2.09%
5/15/2014Varian JohnCEO-10,000$3.55-3.38%
5/15/2014Varian JohnCEO10,000$1.243.50%
5/13/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO-10,000$3.84-11.02%
3/18/2014KURLAND FREDCFO & VP Finance-5,915$6.32-8.63%
3/18/2014Varian JohnCEO-21,329$6.32-6.95%
3/18/2014Neal James RVP Business Development-2,671$6.32-1.73%
3/18/2014Klein ThomasChief Commercial Officer-257$6.32-0.58%
3/18/2014Klein ThomasChief Commercial Officer-30,708$6.32-24.79%
3/18/2014SCANNON PATRICK J MD PHDExec. VP & CSO-3,419$6.32-3.60%
3/18/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO-4,661$6.32-5.54%
3/18/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO-6,988$6.32-7.15%
3/18/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO6,000$3.046.61%
3/18/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO-6,000$6.31-6.20%
3/17/2014Varian JohnCEO10,000$1.243.70%
3/17/2014Varian JohnCEO-10,000$6.03-3.57%
2/18/2014Varian JohnCEO-10,000$7.55-6.30%
2/18/2014Varian JohnCEO10,000$1.246.72%
2/18/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO-6,000$7.55-65.02%
2/18/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO6,000$3.04185.87%
1/21/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO-306$8.27-8.66%
1/21/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO5,694$3.04176.39%
1/21/2014RUBIN PAUL DSr. VP Clinical Dev. & CMO-5,694$8.27-63.82%
1/15/2014Varian JohnCEO-10,000$8.28-6.30%
1/15/2014Varian JohnCEO10,000$1.246.72%
1/09/2014SCANNON PATRICK J MD PHDExec. VP & CSO-20,000$8.00-32.25%
1/09/2014SCANNON PATRICK J MD PHDExec. VP & CSO20,000$1.6947.60%
12/18/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO6,000$3.04169.78%
12/18/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO-6,000$5.67-62.93%
12/16/2013Varian JohnCEO-10,000$5.44-6.30%
12/16/2013Varian JohnCEO10,000$1.246.72%
12/02/2013SCANNON PATRICK J MD PHDExec. VP & CSO-16,665$6.00-28.40%
12/02/2013SCANNON PATRICK J MD PHDExec. VP & CSO16,665$1.6939.66%
12/02/2013SCANNON PATRICK J MD PHDExec. VP & CSO-3,335$6.00-7.35%
12/02/2013SCANNON PATRICK J MD PHDExec. VP & CSO3,335$1.697.94%
11/27/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO-4,696$4.54-57.06%
11/27/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO4,696$3.04132.88%
11/18/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO-1,304$4.08-26.95%
11/18/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO1,304$2.3636.90%
11/15/2013Varian JohnCEO10,000$1.246.72%
11/15/2013Varian JohnCEO-10,000$4.13-6.30%
11/13/2013Varian JohnCEO-52,477$3.91-26.08%
11/13/2013Varian JohnCEO-2,455$3.91-2.28%
11/13/2013SCANNON PATRICK J MD PHDExec. VP & CSO-8,346$3.91-16.57%
11/13/2013KURLAND FREDCFO & VP Finance-12,331$3.91-35.83%
10/18/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO746$2.368.49%
10/18/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO-746$4.71-7.82%
10/15/2013Varian JohnDirector and CEO-10,000$4.60-8.85%
10/15/2013Varian JohnDirector and CEO10,000$1.249.71%
9/30/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO459$4.275.51%
9/18/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO-6,000$4.53-41.87%
9/16/2013Varian JohnDirector and CEO10,000$1.249.71%
9/16/2013Varian JohnDirector and CEO-10,000$4.59-8.85%
8/19/2013BAKER BROS. ADVISORS LPSenior Executive Officer1,854,058$3.6210.35%
8/19/2013BAKER BROS. ADVISORS LPSenior Executive Officer882,323$3.6245.31%
8/19/2013BAKER BROS. ADVISORS LPSenior Executive Officer21,410$3.624.38%
8/19/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO-6,000$3.74-29.51%
8/15/2013Varian JohnDirector and CEO-10,000$3.92-8.85%
8/15/2013Varian JohnDirector and CEO10,000$1.249.71%
8/14/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO-10,520$3.86-34.10%
8/14/2013SCANNON PATRICK J MD PHDExec. VP & CSO-6,002$3.86-17.80%
8/14/2013KURLAND FREDCFO & VP Finance-7,498$3.86-23.04%
8/14/2013Varian JohnDirector and CEO-51,647$3.86-85.97%
7/18/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO2,748$2.3667.01%
7/18/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO-2,748$4.71-40.12%
7/18/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO-3,252$4.71-44.23%
7/18/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO3,252$3.0479.30%
7/15/2013Varian JohnDirector and CEO-10,000$4.81-14.27%
7/15/2013Varian JohnDirector and CEO10,000$1.2416.64%
6/28/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO567$3.4516.04%
6/18/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO3,130$2.3648.88%
6/17/2013Varian JohnDirector and CEO10,000$1.2416.64%
6/11/2013SCANNON PATRICK J MD PHDExec. VP & CSO10,000$1.6957.31%
5/29/2013RUBIN PAUL DSr. VP Clinical Dev. & CMO-1,797$4.16-21.91%
5/28/2013WYSZOMIERSKI JACK LDirector2,800$2.6962.24%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (XOMA), click here.
  • Showing 1-100 of 117 items
  • 1
  • 2
  • >>
Trading Center